November 28, 2022
Learn how sleep apnoea affects blood glucose levels and metabolic health. Discover types of sleep apnoea, risk factors, and effective monitoring techniques for better sleep and blood sugar control.
Do you find yourself waking up gasping for air in the middle of the night? Is your snoring disrupting your roommate's or spouse's sleep? These could be signs of sleep apnoea, a sleep disorder that affects a significant portion of the population.
In this article, we'll delve into sleep apnoea, its connection to blood glucose levels, risk factors, and how monitoring blood sugar levels can aid in effective management.
Sleep apnoea is a sleep disorder characterised by frequent interruptions in breathing during sleep, leading to sleep deprivation. These interruptions, known as apnoeic events, can last for a few seconds to minutes and may occur multiple times throughout the night.
This condition prevents individuals from experiencing deep sleep, which is essential for cellular health and body recovery. Chronic sleep deprivation is associated with various health problems, including metabolic dysregulation, high blood pressure, cardiovascular risks and diabetes development.
Several factors contribute to the development of sleep apnoea, which can be broadly categorised into two main types: obstructive sleep apnoea (OSA) and central sleep apnoea.
This is the most common type of sleep apnoea and occurs when the muscles in the back of the throat relax excessively during sleep. As these muscles relax, the airway narrows or closes, leading to restricted airflow and a temporary pause in breathing. The brain detects the drop in oxygen levels and signals the body to wake up slightly to reopen the airway, often resulting in loud snoring or gasping for air.
Contributing factors:
A recent study in the European Respiratory Journal revealed that the severity of obstructive sleep apnoea increases the risk of type 2 diabetes. These findings highlight the importance of considering diabetes risks when treating the condition.
Unlike OSA, central sleep apnoea is not caused by physical airway blockage. Instead, it arises from a breakdown in communication between the brain and respiratory muscles. The brain fails to send the appropriate signals to initiate breathing, resulting in a temporary cessation of breathing. Unlike OSA, there is no snoring associated with central sleep apnoea.
Contributing factors:
In addition to the primary types of sleep apnoea, a condition known as complex sleep apnoea syndrome, or treatment-emergent central sleep apnoea, can develop. This occurs when someone with OSA begins using continuous positive airway pressure (CPAP) therapy and their central sleep apnoea worsens or emerges as a result.
Detecting sleep apnoea can be challenging, especially if you sleep alone. Common symptoms include:
The connection between sleep apnoea and blood sugar levels is intricate and multifaceted. People with sleep apnoea often experience elevated blood glucose levels, leading to a range of metabolic disturbances. Furthermore, research has indicated that individuals with sleep apnoea are more likely to develop insulin resistance, a key factor in the development of type 2 diabetes.
Sleep apnoea disrupts the normal sleep cycle, causing intermittent awakenings and preventing you from reaching restorative deep sleep. These awakenings can lead to sleep fragmentation, which, in turn, affects your body's ability to regulate high glucose levels in the blood effectively. The disruption in sleep patterns can result in increased insulin resistance and impaired glucose tolerance, causing blood glucose levels to rise, especially during the night.
Insulin resistance is a condition where the body's cells become less responsive to the effects of insulin, leading to higher blood glucose levels. This is a hallmark of type 2 diabetes, a metabolic disorder characterised by chronic elevated blood sugar levels.
Research has shown a clear association between sleep apnoea and type 2 diabetes. People with sleep apnoea or other sleep disorders were twice as likely to develop the condition compared to those without sleep issues. Even more alarming, individuals who slept for less than six hours were also twice as likely to have insulin resistance.
The relationship between sleep apnoea and insulin resistance can be attributed to several factors:
Managing sleep apnoea involves various strategies to improve sleep quality and mitigate health risks. Assessment tools like the Epworth Sleep Scale and StopBang questionnaire aid in identifying sleep apnoea symptoms. Combining these tools with your doctor's recommended treatment plan can help you manage the condition effectively.
Blood sugar management plays a crucial role, particularly for individuals with type 2 diabetes or those at risk of developing it. Continuous Glucose Monitoring (CGM) is a valuable tool for tracking glucose levels and identifying trends that might correlate with sleep apnoea episodes.
Other treatment options include Continuous Positive Airway Pressure (CPAP) therapy, lifestyle interventions and noise reduction techniques. Adopting a healthy nighttime routine, managing noise levels and maintaining a balanced lifestyle contribute to better sleep quality and overall wellbeing.
If you're seeking comprehensive blood sugar level monitoring and sleep apnoea management, consider trying Vively. This metabolic health app utilises continuous glucose monitors to track glucose levels, providing valuable data for lifestyle improvement. Managing glucose levels is pivotal in sleep apnoea treatment, ensuring a healthier and more restful sleep.
Subscribe to our newsletter & join a community of 20,000+ Aussies
Learn how sleep apnoea affects blood glucose levels and metabolic health. Discover types of sleep apnoea, risk factors, and effective monitoring techniques for better sleep and blood sugar control.
Do you find yourself waking up gasping for air in the middle of the night? Is your snoring disrupting your roommate's or spouse's sleep? These could be signs of sleep apnoea, a sleep disorder that affects a significant portion of the population.
In this article, we'll delve into sleep apnoea, its connection to blood glucose levels, risk factors, and how monitoring blood sugar levels can aid in effective management.
Sleep apnoea is a sleep disorder characterised by frequent interruptions in breathing during sleep, leading to sleep deprivation. These interruptions, known as apnoeic events, can last for a few seconds to minutes and may occur multiple times throughout the night.
This condition prevents individuals from experiencing deep sleep, which is essential for cellular health and body recovery. Chronic sleep deprivation is associated with various health problems, including metabolic dysregulation, high blood pressure, cardiovascular risks and diabetes development.
Several factors contribute to the development of sleep apnoea, which can be broadly categorised into two main types: obstructive sleep apnoea (OSA) and central sleep apnoea.
This is the most common type of sleep apnoea and occurs when the muscles in the back of the throat relax excessively during sleep. As these muscles relax, the airway narrows or closes, leading to restricted airflow and a temporary pause in breathing. The brain detects the drop in oxygen levels and signals the body to wake up slightly to reopen the airway, often resulting in loud snoring or gasping for air.
Contributing factors:
A recent study in the European Respiratory Journal revealed that the severity of obstructive sleep apnoea increases the risk of type 2 diabetes. These findings highlight the importance of considering diabetes risks when treating the condition.
Unlike OSA, central sleep apnoea is not caused by physical airway blockage. Instead, it arises from a breakdown in communication between the brain and respiratory muscles. The brain fails to send the appropriate signals to initiate breathing, resulting in a temporary cessation of breathing. Unlike OSA, there is no snoring associated with central sleep apnoea.
Contributing factors:
In addition to the primary types of sleep apnoea, a condition known as complex sleep apnoea syndrome, or treatment-emergent central sleep apnoea, can develop. This occurs when someone with OSA begins using continuous positive airway pressure (CPAP) therapy and their central sleep apnoea worsens or emerges as a result.
Detecting sleep apnoea can be challenging, especially if you sleep alone. Common symptoms include:
The connection between sleep apnoea and blood sugar levels is intricate and multifaceted. People with sleep apnoea often experience elevated blood glucose levels, leading to a range of metabolic disturbances. Furthermore, research has indicated that individuals with sleep apnoea are more likely to develop insulin resistance, a key factor in the development of type 2 diabetes.
Sleep apnoea disrupts the normal sleep cycle, causing intermittent awakenings and preventing you from reaching restorative deep sleep. These awakenings can lead to sleep fragmentation, which, in turn, affects your body's ability to regulate high glucose levels in the blood effectively. The disruption in sleep patterns can result in increased insulin resistance and impaired glucose tolerance, causing blood glucose levels to rise, especially during the night.
Insulin resistance is a condition where the body's cells become less responsive to the effects of insulin, leading to higher blood glucose levels. This is a hallmark of type 2 diabetes, a metabolic disorder characterised by chronic elevated blood sugar levels.
Research has shown a clear association between sleep apnoea and type 2 diabetes. People with sleep apnoea or other sleep disorders were twice as likely to develop the condition compared to those without sleep issues. Even more alarming, individuals who slept for less than six hours were also twice as likely to have insulin resistance.
The relationship between sleep apnoea and insulin resistance can be attributed to several factors:
Managing sleep apnoea involves various strategies to improve sleep quality and mitigate health risks. Assessment tools like the Epworth Sleep Scale and StopBang questionnaire aid in identifying sleep apnoea symptoms. Combining these tools with your doctor's recommended treatment plan can help you manage the condition effectively.
Blood sugar management plays a crucial role, particularly for individuals with type 2 diabetes or those at risk of developing it. Continuous Glucose Monitoring (CGM) is a valuable tool for tracking glucose levels and identifying trends that might correlate with sleep apnoea episodes.
Other treatment options include Continuous Positive Airway Pressure (CPAP) therapy, lifestyle interventions and noise reduction techniques. Adopting a healthy nighttime routine, managing noise levels and maintaining a balanced lifestyle contribute to better sleep quality and overall wellbeing.
If you're seeking comprehensive blood sugar level monitoring and sleep apnoea management, consider trying Vively. This metabolic health app utilises continuous glucose monitors to track glucose levels, providing valuable data for lifestyle improvement. Managing glucose levels is pivotal in sleep apnoea treatment, ensuring a healthier and more restful sleep.
Get irrefutable data about your diet and lifestyle by using your own glucose data with Vively’s CGM Program. We’re currently offering a 20% discount for our annual plan. Sign up here.
Unravel the mystery of insulin resistance, its causes and implications for your health. Explore evidence-based strategies to prevent and manage this condition and optimise your metabolic health.